Live Breaking News & Updates on ஹீமாட்டாலஜி ஆண்டு சந்தித்தல்

Stay updated with breaking news from ஹீமாட்டாலஜி ஆண்டு சந்தித்தல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Syndax Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Clinical and Business Update


Syndax Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Clinical and Business Update
- Today announced two of the prior responders from ongoing Phase 1 portion of AUGMENT-101 trial of SNDX-5613 achieved full count recovery bringing CR/CRh rate up to 23% -
- Company on track to initiate pivotal Phase 2 portion of AUGMENT-101 trial in 2Q21 -
- Enrollment of 23 cGVHD patients in Phase 2 expansion cohort testing axatilimab at 1 mg/kg complete; enrollment ongoing in pivotal AGAVE-201 trial of axatilimab in cGVHD -
- Company to host conference call today at 4:30 p.m. ET -
News provided by
Share this article ....

Briggsw Morrison , Eytan Stein , Eytanm Stein , Melissa Forst , Exchange Commission , International Number , Syndax Pharmaceuticals , Program For Drug Development In Leukemia , Syndax Pharmaceuticals Inc , Drug Administration , Chief Executive Officer , Assistant Attending Physician , Drug Development , Memorial Sloan Kettering Cancer , American Society , Hematology Annual Meeting , Lee Symptom Scale , Orphan Drug Designation , Dial In Number , Cautionary Note , Forward Looking Statements , Private Securities Litigation Reform Act , Months Ended March , மெலிசா பொர்ஸ்ட் , பரிமாற்றம் தரகு , சர்வதேச எண் ,